Design and experiment of flexible clamping device for pepper plug seedlings
Shuangyan, Hu, Minjuan, Hu, Wenyi, Zhang
Published in Advances in mechanical engineering (01.06.2022)
Published in Advances in mechanical engineering (01.06.2022)
Get full text
Journal Article
Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management
Yang, Zhengyu, Wang, Yanan, Chen, Ya, Qian, Fangfei, Zhang, Yanwei, Hu, Minjuan, Zhang, Wei, Han, Baohui
Published in European journal of cardio-thoracic surgery (11.07.2022)
Published in European journal of cardio-thoracic surgery (11.07.2022)
Get full text
Journal Article
Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations
Yang, Zhengyu, Chen, Ya, Wang, Yanan, Wang, Shuyuan, Hu, Minjuan, Zhang, Bo, Han, Baohui
Published in Frontiers in oncology (16.08.2021)
Published in Frontiers in oncology (16.08.2021)
Get full text
Journal Article
Case report: Spontaneous remission in lung carcinoma with a late relapse after adjuvant immunotherapy: Exceptional tumor micro-environment
Chen, Yan, Guan, Wenhui, Zhong, Changhao, Deng, Jiaxi, Hu, Minjuan, Mo, Wenwei, Xie, Xiaohong, Li, Shiyue, Zhou, Chengzhi, Lin, Xinqing
Published in Frontiers in immunology (27.02.2023)
Published in Frontiers in immunology (27.02.2023)
Get full text
Journal Article
Pembrolizumab Plus Chemotherapy Versus Chemotherapy Monotherapy as a First-Line Treatment in Elderly Patients (≥75 Years Old) With Non-Small-Cell Lung Cancer
Yang, Zhengyu, Chen, Ya, Wang, Yanan, Hu, Minjuan, Qian, Fangfei, Zhang, Yanwei, Zhang, Bo, Zhang, Wei, Han, Baohui
Published in Frontiers in immunology (14.02.2022)
Published in Frontiers in immunology (14.02.2022)
Get full text
Journal Article
Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC
Chen, Ya, Yang, Zhengyu, Wang, Yanan, Hu, Minjuan, Zhang, Bo, Zhang, Yanwei, Qian, Fangfei, Zhang, Wei, Han, Baohui
Published in Frontiers in oncology (16.04.2021)
Published in Frontiers in oncology (16.04.2021)
Get full text
Journal Article
TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer
Lu, Jun, Zhong, Runbo, Lou, Yuqing, Hu, Minjuan, Yang, Zhengyu, Wang, Yanan, Chen, Ya, Zou, Benkun, Zhang, Wei, Wang, Huimin, Han, Baohui
Published in Frontiers in immunology (17.09.2021)
Published in Frontiers in immunology (17.09.2021)
Get full text
Journal Article
The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients
Sun, Ni, Li, Ru, Deng, Haiyi, Li, Qingyang, Deng, Jiaxi, Zhu, Yue, Mo, Wenwei, Guan, Wenhui, Hu, Minjuan, Liu, Ming, Xie, Xiaohong, Lin, Xinqing, Zhou, Chengzhi
Published in Frontiers in oncology (25.06.2024)
Published in Frontiers in oncology (25.06.2024)
Get full text
Journal Article
Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis
Chen, Ya, Wang, Shuyuan, Zhang, Bo, Zhao, Yiming, Zhang, Lele, Hu, Minjuan, Zhang, Wei, Han, Baohui
Published in Targeted oncology (01.06.2020)
Published in Targeted oncology (01.06.2020)
Get full text
Journal Article
Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study
Chen, Ya, Wang, Yanan, Yang, Zhengyu, Hu, Minjuan, Zhang, Yanwei, Qian, Fangfei, Zhang, Wei, Zhang, Bo, Han, Baohui
Published in Frontiers in oncology (28.06.2021)
Published in Frontiers in oncology (28.06.2021)
Get full text
Journal Article
CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients
Zhang, Yanwei, Sun, Beibei, Hu, Minjuan, Lou, Yuqing, Lu, Jun, Zhang, Xueyan, Wang, Huimin, Qian, Jialin, Chu, Tianqing, Han, Baohui
Published in Frontiers in oncology (30.06.2020)
Published in Frontiers in oncology (30.06.2020)
Get full text
Journal Article
Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells
Lu, Jun, Xu, Wei, Qian, Jie, Wang, Shuyuan, Zhang, Bo, Zhang, Lele, Qiao, Rong, Hu, Minjuan, Zhao, Yiming, Zhao, Xiaodong, Han, Baohui
Published in BMC medical genomics (13.03.2019)
Published in BMC medical genomics (13.03.2019)
Get full text
Journal Article
Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung
Wang, Yanan, Qian, Fangfei, Chen, Ya, Yang, Zhengyu, Hu, Minjuan, Lu, Jun, Zhang, Yanwei, Zhang, Wei, Cheng, Lei, Han, Baohui
Published in Frontiers in oncology (22.09.2021)
Published in Frontiers in oncology (22.09.2021)
Get full text
Journal Article
ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among TP53-Negative NSCLC Patients
Lu, Jun, Zhang, Yanwei, Lou, Yuqing, Yan, Bo, Zou, Benkun, Hu, Minjuan, Wang, Yanan, Chen, Ya, Yang, Zhengyu, Wang, Huimin, Zhang, Wei, Han, Baohui
Published in Frontiers in genetics (07.09.2021)
Published in Frontiers in genetics (07.09.2021)
Get full text
Journal Article
Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells
Lu, Jun, Xu, Wei, Qian, Jie, Wang, Shuyuan, Zhang, Bo, Zhang, Lele, Qiao, Rong, Hu, Minjuan, Zhao, Yiming, Zhao, Xiaodong, Han, Baohui
Published in BMC medical genomics (08.07.2022)
Published in BMC medical genomics (08.07.2022)
Get full text
Journal Article
PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway
Zhang, Wei, Zhang, Yanwei, Zhou, Wensheng, Qian, Fangfei, Hu, Minjuan, Chen, Ya, Lu, Jun, Lou, Yuqing, Han, Baohui
Published in Cancer cell international (06.01.2021)
Published in Cancer cell international (06.01.2021)
Get full text
Journal Article
The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma
Zhou, Wensheng, Liu, Zhichao, Wang, Yanan, Zhang, Yanwei, Qian, Fangfei, Lu, Jun, Wang, Huimin, Gu, Ping, Hu, Minjuan, Chen, Ya, Yang, Zhengyu, Zhao, Ruiying, Lou, Yuqing, Han, Baohui, Zhang, Wei
Published in Cancer medicine (Malden, MA) (01.03.2022)
Published in Cancer medicine (Malden, MA) (01.03.2022)
Get full text
Journal Article
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update
Lu, Jun, Chu, Tianqing, Liu, Hongyu, Hu, Minjuan, Lou, Yuqing, Zhang, Yanwei, Gao, Zhiqiang, Zhang, Wei, Zhang, Xueyan, Wang, Huimin, Zhong, Hua, Han, Baohui
Published in Chinese journal of cancer research (28.02.2022)
Published in Chinese journal of cancer research (28.02.2022)
Get full text
Journal Article
Local consolidative therapy for synchronous oligometastatic non‐small cell lung cancer treated with first‐line pembrolizumab: A retrospective observational study
Chen, Ya, Wang, Yanan, Yang, Zhengyu, Hu, Minjuan, Lu, Jun, Zhang, Yanwei, Qian, Fangfei, Zhang, Bo, Wang, Shuyuan, Wang, Kai, Zhang, Wei, Han, Baohui
Published in Thoracic cancer (01.03.2022)
Published in Thoracic cancer (01.03.2022)
Get full text
Journal Article